Shi Wei Bai Du Tang Capsule
Natural health product licensed in Canada
- Other names
- Cyctek Shi Wei Bai Du Tang Capsule
- Licence holder
- CycTek Inc.
- NPN or DIN-HM
- 80144809
- Status
- Active licence
- Licence date
- 17 October 2025
- Revision date
- Not provided
- Form
- Capsule, dur
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
- Conditions légales
Platycodon grandiflorus (Jacq.) A.DC.: L'étiquetage doit comporter un avertissement déconseillant un usage prolongé, tel que "L'usage prolongé peut irriter l'estomac".
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Glycyrrhiza glabra L.: La portion journalière recommandée ne doit pas conduire à une ingestion d'acide glycyrrhizinique supérieure à 100 mg. L'étiquetage doit comporter un avertissement avec la teneur suivante: "Ne pas utiliser pendant plus de 6 semaines sans avis médical." L'étiquetage doit comporter un avertissement déconseillant l'emploi chez les enfants.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Ligusticum sinense cv. chuanxiong Source : Rhizome Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 600 mg | 60 mg | Not calculated |
| Nepeta tenuifolia Source : Sommité (herbe) Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 200 mg | 20 mg | Not calculated |
| Bupleurum chinense Source : Racine Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 600 mg | 60 mg | Not calculated |
| Angelica pubescens Source : Racine Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 600 mg | 60 mg | Not calculated |
| Platycodon grandiflorus Source : Racine Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 600 mg | 60 mg | Not calculated |
| Rosa laevigata Source : Fruit Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 600 mg | 60 mg | Not calculated |
| Saposhnikovia divaricata Source : Racine Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 600 mg | 60 mg | Not calculated |
| Zingiber officinale Source : Rhizome Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 200 mg | 20 mg | Not calculated |
| Glycyrrhiza glabra Source : Racine et rhizome Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 200 mg | 20 mg | Not calculated |
| Wolfiporia extensa Source : Sclerotium Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 800 mg | 80 mg | Not calculated |
Non-medicinal ingredients
Cellulose, Hypromellose, Stéarate de magnésium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 18 years | 2 Capsule | 2 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Combination of Traditional Chinese Medicine Ingredients.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80144809
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Zingiber officinale
Read the warning, when it applies and the studies cited
GINGER - ZINGIBER OFFICINALE
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
- Glycyrrhiza glabra
Read the warning, when it applies and the studies cited
DEGLYCYRRHIZINATED LICORICE Buccal
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Health Canada monograph dated 31 October 2025
Deglycyrrhizinated Licorice Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Health Canada monograph dated 31 January 2025
LICORICE
Route of administration: Oral
Cautions and warnings
Condition of application: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are breastfeeding (Gardner and McGuffin 2013).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Condition of application: Cough relief.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if cough worsens or persists (for) more than 1 week (EMA 2012).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Condition of application: Gastritis relief.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Contraindications
Condition of application: All products.
Do not use if you are pregnant (EMA 2012).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Do not use if you have hypokalemia, high blood pressure, or a kidney, liver or cardiovascular disorder (EMA 2012; Brinker 2010; ESCOP 2003; Bradley 1992).
4 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Do not use if you are taking heart medications, corticosteroids, stimulant laxatives, or other health products that may contribute electrolyte imbalance (Brinker 2010; ESCOP 2003; Hoffmann 2003; Blumenthal et al. 2000).
4 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
They concern the ingredient, not this product or its dose. They do not replace medical advice.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.